Greylock XI GP Limited Partnership - AVEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Greylock XI GP Limited Partnership ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$707,000
-30.4%
584,0040.0%9.17%
-12.5%
Q2 2015$1,016,000
+20.0%
584,0040.0%10.48%
+31.1%
Q1 2015$847,000
+72.5%
584,0040.0%7.99%
-92.0%
Q4 2014$491,000
-24.2%
584,0040.0%100.00%0.0%
Q3 2014$648,000
-39.3%
584,0040.0%100.00%0.0%
Q2 2014$1,068,000
+21.9%
584,0040.0%100.00%
+17821.1%
Q1 2014$876,000
-18.1%
584,0040.0%0.56%
+48.8%
Q4 2013$1,069,000
-11.1%
584,0040.0%0.38%
+17.6%
Q3 2013$1,203,000
-17.6%
584,0040.0%0.32%
+84.4%
Q2 2013$1,460,000584,0040.17%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Deer VI & Co. LLC 675,242$1,958,000100.00%
NEA Management Company, LLC 16,362,694$47,452,0002.11%
Prosight Management, LP 1,043,550$3,026,0001.90%
New Leaf Venture Partners, L.L.C. 964,520$2,797,0001.51%
RA Capital Management 5,062,759$14,682,0001.12%
X-Square Capital, LLC 231,434$671,0000.71%
683 Capital Management, LLC 2,500,000$7,250,0000.64%
Avoro Capital Advisors LLC 3,231,893$9,372,0000.45%
EAM Global Investors LLC 244,768$710,0000.37%
Polar Capital LLP 7,877,429$22,845,0000.23%
View complete list of AVEO PHARMACEUTICALS INC shareholders